| Symbol | ARCT |
|---|---|
| Name | ARCTURUS THERAPEUTICS HOLDINGS INC. |
| Sector | HEALTH CARE |
| Region | Middle East |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 10628 SCIENCE CENTER DRIVE,SUITE 250, SAN DIEGO, California, 92121, United States |
| Telephone | +1 858 900-2660 |
| Fax | — |
| — | |
| Website | https://www.arcturusrx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001768224 |
| Description | Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. Additional info from NASDAQ: |
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Read more(70% Positive) ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Provides Update on leader for Cystic Fibrosis
Read moreArcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
Read moreDirector HOLMES EDWARD W 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000829
Read moreDirector FARRELL PETER C 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000828
Read moreDirector BARLOW JAMES F 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000827
Read moreDirector Markels John 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000826
Read moreDirector Slaoui Moncef 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000825
Read moreDirector Marquet Magda 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000824
Read moreDirector Marantz Jing L. 🟢 acquired 15.0K shares (1 derivative) of Arcturus Therapeutics Holdings Inc. (ARCT) at $7.30 Transaction Date: Jun 05, 2026 | Filing ID: 000823
Read more